Phase 1 Cancer Cachexia Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants
Cancer CachexiaCancer Cachexia (CC)
Shenzhen Kexing Pharmaceutical Co., Ltd.36 enrolled1 locationNCT07237464
Recruiting
Phase 1
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
Cancer Cachexia
Genfleet Therapeutics (Shanghai) Inc.36 enrolled1 locationNCT06898255